facebook

Helios Rising

Scheme Rating

IME Scheme Rating

3 of 5 stars

Good Option: Rising India PMS is still young, however, the strong AMC pedigree, experienced team and good strategy make it a strong multi-cap strategy option for investors.

IME Strategy Rating

4 of 5 stars

Theme Based Aprroach: The Strategy centers on theme-based stock selection, capitalizing on India’s growth drivers such as privatization, demographic shifts, and global competitiveness. It follows a diversified portfolio approach with a focus on negative selection to identify 2 kinds of stocks – “high confidence in reasonable returns” (10-20 stocks) and “reasonable confidence in -high returns” (20-30 stocks).

PMS Scheme Ratings are driven by IME’s Proprietary Scheme Rating Methodology, which takes into account our ratings of the Scheme’s investment strategy, its maturity, the investment team, and our separate rating on the AMC that runs this particular scheme. Our views on each of these individual criteria are available via the IME RMS – which you can view by reaching out to one of our relationship managers (using either the live chat or book appointment feature on this site).

IME View on Helios Rising

Type: Large & Midcap | GARP | AUM (1466.7 cr) | Inc Date (16 Mar 2020)

Investment Philosophy

Helios believe that strong and consistent portfolio returns come from both stock selection and careful portfolio construction. They build a portfolio on the basis of: 

  • What stocks to buy
  • What is their time horizon 
  • How many stocks to own  
  • When to sell

Investment Strategy

Themes to avoid 

  • Commodities 
  • ‘One billion consumer stories’- sectors where investors rely on billion plus Indian population to justify the opportunity 
  • State-owned companies 
  • Bet on India, not on Indians

Sell Strategy 

Sell when there is deterioration in fundamental developments, or when stock returns significantly outperform underlying earnings growth, high valuation. 

Invesment Process

  • Universe: 500 companies
  • Level 1: rejecting stocks to 275 stocks on the basis of favoured themes
  • Level 2: rejection based on industry dynamics, envisaged disruption, company management strength, corporate governance, financial analysis, medium-term triggers, valuation to be able to arrive at 150 stocks
  • Level 3: rejection consists of rigorous bottom-up research to arrive at an investable universe of 60 stocks
  • Portfolio: Handpick stocks that give high confidence to build a portfolio of 30-35 stocks

Portfolio Construction

The number of stocks to own at a time is driven by a robust portfolio that needs to have 2 kinds of stocks

  • Stocks offering “High confidence in reasonable returns”: 10 to 15 stocks (50-60% weight)
  • Stocks offering “Reasonable confidence in high returns”: 15 to 25 stocks (40-50% weight) 

Trailing Performance

1yr 3yr 5yr Since Inception
Helios Rising 40.6 17.6 27.6
S&P BSE 500 TRI 41.1 18.9 28.6
Alpha over Broad Mkt BM -0.5 -1.3 -1
Nifty 500 40.2 17.7
Alpha over Category BM 0.4 -0.1

Performance as of: 31-Aug-24 | Inception Date: 16-Mar-20

Fund Managers

Samir Arora | 5-star rated FM

Founder & CEO, Fund Manager | 33 yrs Experience | 19 yrs at current firm

Past Experience: Head of Asian Emerging Markets (Alliance Capital Management)

Samir Arora is the Founder and Fund Manager of Helios Singapore. He has been managing FII funds with India-dedicated long and long-short strategies for the past 17 years at Helios. Prior to Helios, Samir was the Head of Asian Emerging Markets at Alliance Capital Management. He started his career at Alliance Capital as an International Analyst covering sectors in Japan, Australia and New Zealand. He later relocated to India as Fund Manager and CIO of Alliance Capital’s Mutual Fund business until 2003 before moving to Singapore to become Head of Asian EM. Samir Arora is a highly respected veteran of the Indian markets and has been recognised for his fund management skillsets as evident from the various awards he had won during his tenure at Alliance. He is an MBA graduate from IIM-C and received his undergrad in engineering from IIT Delhi. He also received a master’s degree in finance from the Wharton School of the University of Pennsylvania.

Dinshaw Irani | 4-star rated FM

CIO | 31 yrs Experience | 19 yrs at current firm

Past Experience: Executive Director (Artemis Advisors – Research Advisors to Helios Singapore), Principle Portfolio Manager (SSKI Portfolio Advisors), VP and Analyst – Asian EM (Alliance Capital Management), Analyst (Sun F&C AMC)

Dinshaw Irani is the CIO of Helios India. Prior to this, he was the executive director at Artemis Advisors (exclusive research advisors to Helios Singapore) for 14+ years. Dinshaw started his career as an Analyst at Sun F&C Mutual Fund and at Lloyd Securities. He later went on to become the VP of the Asian Emerging Market team for Alliance Capital (Mumbai) for 3 years covering consumer and pharma sectors.

Fee Structure

Fee StructureFee
Fixed Fee Structure2.5
Variable Fee Structures1.5% fixed + 15% above 10% hurdle
Exit Fees

AMC

AMC: Helios PMS (click link for detailed AMC review)

Can be considered for investment: Helios India shares resources with Helios Singapore (the same team manages/advises FII fund, and the same team manages/advises both long-only and long-short strategy), this makes it not just another new PMS from scratch. Helios Singapore has 25 years of experience in Indian equities managing FII funds. Samir Arora and Dinshaw Irani come with over 25+ years of experience respectively.

AMC Rating

3 of 5 stars

AMC Pedigree

4 of 5 stars

AMC Size

3 of 5 stars

Team Pedigree

5 of 5 stars

Inv Philosophy

4 of 5 stars

Performance

3 of 5 stars

Free 30-Day Trial of the IME RMS

Details shared above, are only a short-snapshot of the more detailed analysis that resides in IME’s Proprietary RMS (Research Management Solution).

The IME RMS is the first tool ever, to give investors direct access to the insights of the central research team. Investors gain direct access to our ratings, rating rationales & analysis across thousands of funds (MFs, PMSs, AIFs, Global funds), asset classes, categories & more.

 Learn More

IME RMS Demo

Register 30-Day Trial

Note: PMS AMC & Scheme Reviews and Ratings are based on IME Capital’s Proprietary Review and Rating Methodology (read more here: AMC Rating & Scheme Ratings). These reflect the unbiased views of our central research team, based on our assessment of the investment value of these PMS/AIF strategies for our investors. We follow a highly stringent rating-criteria, where approximately 50% of PMS AMC’s & strategies would be rated 2-star or below (this is not meant to indicate that these funds are not investment-worthy, but that they do not currently fulfill the requirements we focus on for recommending funds to our investors — based on our internal views on the merit of the AMC/strategy relative to peers). Reviews & Ratings are primarily based on research of publicly available information (SEBI disclosures, PMS websites, PMS-aggregation platforms, webinar recording, media interviews etc.) and no explicit consent is required from AMCs for the same. While we endeavour to do further due-diligence via direct interactions with the investment teams of AMCs, this is typically restricted to AMC’s that meet our foundational fund selection criteria (reviews on lower-rated AMCs are often based solely on publicly available information). The views reflected in our Reviews & Ratings, are our independent views and may not be shared by the AMC’s and the investment teams. Please read detailed disclaimer for more.

CONNECT WITH US

Use our Live Chat
Book 15-min Introductory Call
WhatsApp us @ +91 96320 07774

IME Capital Pvt. Ltd. is a research-first investments firm. We aim to disrupt the wealth management industry, by shrinking the gap in investment insights between central research teams & RMs/Clients. 

Products
Solutions
Disclaimer MF/PMS/AIF/Direct Equities are all subject to market risks. Please read the scheme information and other related documents carefully prior to investing. Past performance is not indicative of future returns. Please consider your specific investment requirements before choosing a fund or designing a portfolio that suits your needs. Market & other data on this site has been sourced from what are considered to be reliable sources. All views shared (product ratings, views on individual securities etc.) are the proprietary property of IME Capital and cannot be used in any form without explicit written consent. IME Capital Pvt. Ltd. makes no warranties or representations, express or implied, on products offered through the platform (and that of our partners) or on the correctness of data & views shared. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Detailed Disclaimer © 2021 All rights reserved | ARN No: ARN-182445